Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

There's no significant link between blood fat levels and male pattern baldness.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Combining yoga and certain herbs can effectively manage PCOS symptoms and improve quality of life.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Women with acne often have higher levels of male hormones and are more likely to be overweight, both of which can make acne worse.

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.

Men with type 2 diabetes often have low testosterone and signs of hypogonadism, especially if they are overweight.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.